Document is current
Any future updates will be listed below
-
Authors
Shi, Yadong
Campos, Leonardo
Yamada, Kentaro
Michimoto, Kenkichi
Saiga, Atsushi
Farsad, Khashayar https://orcid.org/0000-0002-3127-7147
- License Information
-
More Information
Article History
Received: 20 December 2024
Accepted: 22 March 2025
First Online: 10 April 2025
Declarations
:
: Khashayar Farsad: Research: Guerbet, W.L. Gore, AstraZeneca; Consulting: Baylis Medical, Neuwave, Inquis; Equity: Auxetics, Inc. Kentaro Yamada: Consulting: Kaneka Medical America, GE Healthcare. The other authors declared nothing to disclosure.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The Institutional Review Board of the study hospital approved this study protocol.
: This study has obtained IRB approval from Nanjing First Hospital and the need for informed consent was waived.
: For this type of study, consent for publication is not required.
